Literature DB >> 21196595

Prevalence of musculoskeletal pain and rheumatic diseases in the southeastern region of Mexico. A COPCORD-based community survey.

José Alvarez-Nemegyei1, Ingris Peláez-Ballestas, Luz Helena Sanin, Mario H Cardiel, Angelica Ramirez-Angulo, Maria-Victoria Goycochea-Robles.   

Abstract

OBJECTIVE: To assess the prevalence of musculoskeletal (MSK) pain and rheumatic diseases in the southeastern Mexican state of Yucatán.
METHODS: Using the Community Oriented Program in the Rheumatic Diseases (COPCORD) methodology, we performed a door-to-door, cross-sectional study generated through a multistage, stratified, randomized method on 3915 adult residents (age 42.7 ± 17.1 yrs; women 61.8%; urban setting 45.7%) of the Mexican state of Yucatán. We used universally accepted criteria for the diagnosis or classification of rheumatoid arthritis (RA), osteoarthritis (OA; knee and hand), fibromyalgia, systemic lupus erythematosus (SLE), gout, ankylosing spondylitis, regional rheumatic pain syndromes, and inflammatory back pain.
RESULTS: Nontraumatic MSK pain in the last 7 days was present in 766 (19.6%; 95% CI 18.3-20.8) individuals. MSK pain was more prevalent in women (26.6%) versus men (12.2%; p < 0.01). Self-reported MSK disability occurred in 1.7%. Most MSK pain-related variables were consistently more prevalent in the urban setting. The prevalence of rheumatic disease was: OA 6.8% (95% CI 6.0-7.6); back pain 3.8% (95% CI 3.2-4.4); RA 2.8% (95% CI 2.2-3.3); rheumatic regional pain syndromes 2.3% (95% CI 1.9-2.8); inflammatory back pain 0.7% (95% CI 0.5-1.0); fibromyalgia 0.2% (95% CI 0.1-0.4); gout 0.1% (95% CI 0.07-0.3); and SLE 0.07% (95% CI 0.01-0.2).
CONCLUSION: The prevalence of MSK pain was 19.6%. MSK pain was more prevalent in women and in the urban setting. A remarkably high prevalence of RA was found in this population, which suggests a role for geographic factors.

Entities:  

Mesh:

Year:  2011        PMID: 21196595     DOI: 10.3899/jrheum.100954

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  25 in total

1.  Educational impact of a clinical anatomy workshop on 1st-year orthopedic and rheumatology fellows in Mexico City.

Authors:  M A Saavedra; P Villaseñor-Ovies; L A Harfush; J E Navarro-Zarza; J J Canoso; P Cruz-Domínguez; A Vargas; C Hernández-Díaz; K Chiapas-Gasca; J Camacho-Galindo; J Alvarez-Nemegyei; R A Kalish
Journal:  Clin Rheumatol       Date:  2015-09-23       Impact factor: 2.980

2.  Mexican rheumatology: where do we stand?

Authors:  Carlos Pineda; Hugo Sandoval; Antonio Fraga-Mouret
Journal:  Rheumatol Int       Date:  2018-11-12       Impact factor: 2.631

3.  Oral health and orofacial function in patients with rheumatoid arthritis.

Authors:  Susana Aideé González-Chávez; César Pacheco-Tena; Teresita de Jesús Caraveo-Frescas; Celia María Quiñonez-Flores; Greta Reyes-Cordero; Rosa María Campos-Torres
Journal:  Rheumatol Int       Date:  2019-09-17       Impact factor: 2.631

Review 4.  Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis.

Authors:  Gustavo Citera; Wilson Bautista-Molano; Ingris Peláez-Ballestas; Valderilio F Azevedo; Risto A Perich; José A Méndez-Rodríguez; Mariel S Cutri; Cecilia E Borlenghi
Journal:  Adv Rheumatol       Date:  2021-01-08

5.  Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: a COPCORD study.

Authors:  Ysabel Granados; Ligia Cedeño; Celenia Rosillo; Sol Berbin; Miriam Azocar; María Elena Molina; Onelia Lara; Gloris Sanchez; Ingris Peláez-Ballestas
Journal:  Clin Rheumatol       Date:  2014-06-13       Impact factor: 2.980

Review 6.  The role of antipsychotics in the management of fibromyalgia.

Authors:  Elena P Calandre; Fernando Rico-Villademoros
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

Review 7.  Psoriatic arthritis: Epidemiology, diagnosis, and treatment.

Authors:  Jung-Tai Liu; Horng-Ming Yeh; Shyun-Yeu Liu; Kow-Tong Chen
Journal:  World J Orthop       Date:  2014-09-18

8.  Prevalence of musculoskeletal disorders in Azar cohort population in Northwest of Iran.

Authors:  Sousan Kolahi; Alireza Khabbazi; Aida Malek Mahdavi; Amid Ghasembaglou; Arezoo Ghasembaglou; Nayyereh Aminisani; Mohammad Hossein Somi; Fariba Heidari
Journal:  Rheumatol Int       Date:  2017-02-06       Impact factor: 2.631

9.  WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran.

Authors:  Nasrin Moghimi; Fereydoun Davatchi; Ezat Rahimi; Afshin Saidi; Naser Rashadmanesh; Solmaz Moghimi; Hoshyar Ghafori; Peiman Zandi; Negin Ahmadi; Hamed Ghafori; Mohsen Moghimi; Marjan hajiheshmati
Journal:  Clin Rheumatol       Date:  2013-11-09       Impact factor: 2.980

10.  Prevalence of musculoskeletal disorders and rheumatic diseases in Cuenca, Ecuador: a WHO-ILAR COPCORD study.

Authors:  Sergio Guevara-Pacheco; Astrid Feicán-Alvarado; Luz Helena Sanín; Jaime Vintimilla-Ugalde; Fernando Vintimilla-Moscoso; Jorge Delgado-Pauta; Angelita Lliguisaca-Segarra; Holger Dután-Erráez; Daniel Guevara-Mosquera; Verónica Ochoa-Robles; Mario H Cardiel; Ingris Peláez-Ballestas
Journal:  Rheumatol Int       Date:  2016-03-29       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.